International Journal of Oral & Maxillofacial Surgery
Volume 39, Issue 5 , Pages 440-445 , May 2010

Intra-articular injection of tenoxicam following temporomandibular joint arthrocentesis: a pilot study

  • I. Aktas

      Affiliations

    • Istanbul University, School of Dentistry, Department of Oral and Maxillofacial Surgery, 34093 Capa, Istanbul, Turkey
    • Corresponding Author InformationAddress: Irem Aktas, Dr. Kemal Akgüder Cd. Yeniyol Sk. Melek Apt. 15/14, 81110 Bostanci, Istanbul, Turkey. Tel.: +90 532 564 47 93; fax: +90 216 363 55 39.
  • ,
  • S. Yalcin

      Affiliations

    • Istanbul University, School of Dentistry, Department of Oral and Maxillofacial Surgery, 34093 Capa, Istanbul, Turkey
  • ,
  • S. Sencer

      Affiliations

    • Istanbul University, School of Medicine, Department of Neuroradiology, 34093 Capa, Istanbul, Turkey

,Accepted 5 February 2010.

References 

  1. Alagol A, Calpur OU, Usar PS, Turan N, Pamukcu Z. Intraarticular analgesia after arthroscopic knee surgery: comparison of neostigmine, clonidine, tenoxicam, morphine and bupivacaine. Knee Surg Sports Traumatol Arthrosc. 2005;13:658–663
  2. Al-Belasy FA, Dolwick MF. Arthrocentesis for the treatment of temporomandibular joint closed lock: a review article. Int J Oral Maxillofac Surg. 2007;36:773–782
  3. American Association of Oral Maxillofacial Surgeons . Parameters of Care for Oral and Maxillofacial Surgery. A Guide for Practice, Monitoring and Evaluation (AAOMS Parameters of Care-95). 1995;205–208
  4. Colbert ST, Curran E, O’Hanlon DM, Moran R, McCarroll M. Intraarticular tenoxicam improves postoperative analgesia in knee arthroscopy. Can J Anaesth. 1999;46:653–657
  5. de Leeuw R, Boering G, Stegegna B, de Bont LG. Radiographic signs of temporomandibular joint osteoarthrosis and internal derangement 30 years after nonsurgical treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:382–392
  6. Dworkin SF, Le Resche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992;6:301–355
  7. Ethunandan M, Wilson AW. Temporomandibular joint arthrocentesis—more questions than answers?. J Oral Maxillofac Surg. 2006;64:952–955
  8. Frost DE, Kendell BD. The use of arthrocentesis for treatment of temporomandibular joint disorders. J Oral Maxillofac Surg. 1999;57:583–587
  9. Guler G, Karaoglu S, Velibasoglu H, Ramazanogullari N, Boyaci A. Comparison of analgesic effects of intra-articular tenoxicam and morphine in anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 2002;10:229–232
  10. Hosaka H, Murakami K, Goto K, Iizuka T. Outcome of arthrocentesis for temporomandibular joint with closed lock at 3 years follow-up. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;82:501–504
  11. Iida K, Kurita K, Tange K, Yoshida K. Necrosis of the articular tubercle after repeated injections of sodium hyaluronate in the temporomandibular joint: a case report. Int J Oral Maxillofac Surg. 1998;27:278–279
  12. Ishimaru JI, Ogi N, Mizui T, Miyamoto K, Shibata T, Kurita K. Effects of a single arthrocentesis and a COX-2 inhibitor on disorders of temporomandibular joints. A preliminary clinical study. Br J Oral Maxillofac Surg. 2003;41:323–328
  13. Kaneyama K, Segami N, Nishimura M, Sato J, Fujimura K, Yoshimura H. The ideal lavage volume for removing bradykinin, interleukin-6, and protein from the temporomandibular joint by arthrocentesis. J Oral Maxillofac Surg. 2004;62:657–661
  14. Kunjur J, Anand R, Brennan PA, Ilankovan V. An audit of 405 temporomandibular joint arthrocentesis with intra-articular morphine infusion. Br J Oral Maxillofac Surg. 2003;41:29–31
  15. Larheim TA, Westesson PL, Hicks DG, Eriksson L, Brown DA. Osteonecrosis of the temporomandibular joint: correlation of magnetic resonance imaging and histology. J Oral Maxillofac Surg. 1999;57:888–898
  16. Nishimura M, Segami N, Kaneyama K, Suzuki T. Prognostic factors in arthrocentesis of the temporomandibular joint: evaluation of 100 patients with internal derangement. J Oral Maxillofac Surg. 2001;59:874–877
  17. Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamaru M. Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:328–332
  18. Nitzan DW, Dolwick MF, Martinez GA. Temporomandibular joint arthrocentesis: a simplified treatment for severe, limited mouth opening. J Oral Maxillofac Surg. 1991;49:1163–1167
  19. Nitzan DW, Samson B, Better H. Long-term outcome of arthrocentesis for sudden-onset, persistent, severe closed lock of the temporomandibular joint. J Oral Maxillofac Surg. 1997;55:151–157
  20. Okeson JP. Management of Temporomandibular Disorders and Occlusion. 4th ed.. St. Louis: Mosby-Year Book, Inc.; 1998;
  21. Oztuna V, Eskandari M, Bugdayci R, Kuyurtar F. Intra-articular injection of tenoxicam in osteoarthritic knee joints with effusion. Orthopedics. 2007;30:1039–1042
  22. Ozyucaci H, Bilgic B, Ozyuvaci E, Altan A, Altug T, Karaca C. Intra-articular injection of tenoxicam in rats: assessment of the local effects on the articular cartilage and synovium. J Int Med Res. 2004;32:312–316
  23. Quinn JH, Bazan NG. Identification of prostoglandin E2 and leukotriene B4 in synovial fluid of painful, dysfunctional temporomandibular joints. J Oral Maxillofac Surg. 1990;48:968–971
  24. Sato S, Kawamura H. Changes in condylar mobility and radiographic alterations after treatment in patients with non-reducing disc displacement of the temporomandibular joint. Dentomaxillofac Radiol. 2006;35:289–294
  25. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA. 1994;91:12013–12017
  26. Shore NA. Occlusal Equilibration and Temporomandibular Joint Dysfunction. Philadelphia: JB Lippincott Co.; 1959;
  27. Simon LS, Lanza FL, Lipsky PE, Hubbard RC, Talwalker S, Schwartz BD, et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum. 1998;41:1591–1602
  28. Stegegna B, de Bont LG, Boering G, Van Willigen JD. Tissue responses to degenerative changes in the temporomandibular joint: a review. J Oral Maxillofac Surg. 1991;49:1079–1088
  29. Swift JQ, Roszkowski MT, Alton T, Hargreaves KM. Effect of intra-articular versus systemic anti-inflammatory drugs in a rabbit model of temporomandibular joint inflammation. J Oral Maxillofac Surg. 1998;56:1288–1295
  30. Talu GK, Özyalçın S, Koltka K, Ertürk E, Akıncı Ö, Aşık M, et al. Comparison of efficacy of intraarticular application of tenoxicam, bupivacaine and tenoxicam: bupivacaine combination in arthroscopic knee surgery. Knee Surg Sports Traumatol Arthrosc. 2002;10:355–360
  31. Tasaki MM, Westesson PL. Temporomandibular joint: diagnostic accuracy with sagittal and coronal MR imaging. Radiology. 1993;186:723–729
  32. Truelove EL, Sommers EE, Leresche L, Dworkin SF, Von Korff M. Clinical diagnostic criteria for TMD. New classification permits multiple diagnosis. JADA. 1992;123:47
  33. Towheed TE, Hochberg MC. A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. Semin Arthritis Rheum. 1997;26:755–770
  34. Westesson PL, Brooks SL. Temporomandibular joint: relationship between MR evidence of effusion and the presence of pain and disc displacement. AJR Am J Roentgenol. 1992;159:559–563

PII: S0901-5027(10)00053-6

doi: 10.1016/j.ijom.2010.02.010

International Journal of Oral & Maxillofacial Surgery
Volume 39, Issue 5 , Pages 440-445 , May 2010